Skip to content

Clinical trials

Phase 3 trials in Algeria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Algeria Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20127
20134
20146
20152
20163
20172
20181
20196
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S21
Hoffmann-La Roche5
Centre Hospitalier Universitaire Ibn Rochd2
International Atomic Energy Agency2
Novartis Pharmaceuticals2
AbbVie1
El Kendi Pharmaceuticals Manufacturing Company1
Immunic AG1
International Cancer Research Group, United Arab Emirates1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 214
Diabetes Mellitus10
Breast Neoplasms4
Hemophilia A3
Infertility2
Fibrosis1
Hemophilia B1
Hepatitis C1
Hepatitis C, Chronic1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.